By Marie Rosenthal, MS
Individuals who have both HIV and risk factors for cardiovascular disease were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV, according to a new study (J Am Heart Assoc 2017 Nov 14. [Epub ahead of print], doi.org/10.1161/JAHA.117.007107).
Because patients with HIV are living longer due to the widespread availability of effective antiretroviral therapy, CVD is emerging as a major cause of death. In the United States,